Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Wallach

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Drug Testing and Analysis|June 7, 2016
Return of the lysergamides. Part II: Analytical and behavioural characterization of N<sup>6</sup> -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ)Simon D Brandt, Pierce V Kavanagh, Folker Westphal, et al.
Drug Testing and Analysis|June 7, 2017
Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775)Simon D Brandt, Pierce V Kavanagh, Brendan Twamley, et al.
The Journal of Biological Chemistry|November 6, 2025
Prolintane analogs as hybrid monoamine transporter ligands: Structural determinants and species differencesNina Kastner, Mohammad N Islam, Michael Dybek, et al.
Journal of Medicinal Chemistry|February 10, 2026
Bioisostere-Driven Discovery of SePP: A Selenium-Containing Polypharmacological Agent Relevant to Fragile X SyndromeJason Wallach, Sean Cameron, Michael Dybek, et al.
Nature Communications|December 15, 2023
Identification of 5-HT<sub>2A</sub> receptor signaling pathways associated with psychedelic potentialJason Wallach, Andrew B Cao, Maggie M Calkins, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
Identification of 5-HT<sub>2A</sub> Receptor Signaling Pathways Responsible for Psychedelic PotentialJason Wallach, Andrew B Cao, Maggie M Calkins, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Drug Testing and Analysis|June 7, 2016
Return of the lysergamides. Part II: Analytical and behavioural characterization of N<sup>6</sup> -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ)Simon D Brandt, Pierce V Kavanagh, Folker Westphal, et al.
Drug Testing and Analysis|June 7, 2017
Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775)Simon D Brandt, Pierce V Kavanagh, Brendan Twamley, et al.
The Journal of Biological Chemistry|November 6, 2025
Prolintane analogs as hybrid monoamine transporter ligands: Structural determinants and species differencesNina Kastner, Mohammad N Islam, Michael Dybek, et al.
Journal of Medicinal Chemistry|February 10, 2026
Bioisostere-Driven Discovery of SePP: A Selenium-Containing Polypharmacological Agent Relevant to Fragile X SyndromeJason Wallach, Sean Cameron, Michael Dybek, et al.
Nature Communications|December 15, 2023
Identification of 5-HT<sub>2A</sub> receptor signaling pathways associated with psychedelic potentialJason Wallach, Andrew B Cao, Maggie M Calkins, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
Identification of 5-HT<sub>2A</sub> Receptor Signaling Pathways Responsible for Psychedelic PotentialJason Wallach, Andrew B Cao, Maggie M Calkins, et al.
Pageof 4